Jan 14, 2020 / 12:30AM GMT
David James Adlington - JP Morgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research
Great. Good afternoon, everybody. I'm David Adlington, head of the research group for the European medtech and services in London. It's my pleasure to introduce Rice Powell, CEO of Fresenius Medical Care. There is no breakout session afterwards. Thanks.
Robert Maurice Powell - Fresenius Medical Care AG & Co. KGaA - Chairman of the Management Board & CEO of Fresenius Medical Care Mgmt AG
Thank you, David. Before I get into my prepared remarks, I'd like to introduce to you, she's down here in front, Helen Giza, our new CFO. She's been here 60 days, and she's still standing. That's a good thing. Helen, please.
So you'll notice up on the top left, we're talking about 2018. I'm not living in a time warp, but 2018 is the last full year set of numbers we have at the moment. We haven't done Q4, so we're going to give you some view of '18 as a baseline, and then I'll go through the third quarter earnings and give you some detail
Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers